Document Detail

Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants.
MedLine Citation:
PMID:  19443704     Owner:  NLM     Status:  MEDLINE    
It is assumed that the onset and course of autoimmune inflammatory central nervous system (CNS) disorders (eg, multiple sclerosis) are influenced by factors that afflict immune regulation as well as CNS vulnerability. We challenged this concept experimentally by investigating how genetic alterations that affect myelin (primary oligodendrocyte damage in PLPtg mice) and/or T-cell regulation (deficiency of PD-1) influence both the onset and course of an experimental autoimmune CNS inflammatory disease [MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE)]. We observed that double pathology was associated with a significantly earlier onset of disease, a slight increase in the neurological score, an increase in the number of infiltrating cells, and enhanced axonal degeneration compared with wild-type mice and the respective, single mutant controls. Double-mutant PLPtg/PD-1(-/-) mice showed an increased production of interferon-gamma by CNS immune cells at the peak of disease. Neither PD-1 deficiency nor oligodendropathy led to detectable spread of antigenic MHC class I- or class II-restricted epitopes during EAE. However, absence of PD-1 clearly increased the propensity of T lymphocytes to expand, and the number of clonal expansions reliably reflected the severity of the EAE disease course. Our data show that the interplay between immune dysregulation and myelinopathy results in a stable exacerbation of actively induced autoimmune CNS inflammation, suggesting that the combination of several pathological issues contributes significantly to disease susceptibility or relapses in human disease.
Antje Kroner; Nicholas Schwab; Chi Wang Ip; Sonja Ortler; Kerstin Göbel; Klaus-Armin Nave; Mathias Mäurer; Rudolf Martini; Heinz Wiendl
Related Documents :
14678264 - The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experi...
17634104 - Modulation of microglial/macrophage activation by macrophage inhibitory factor (tkp) or...
7540264 - Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple scle...
12906764 - Eae in the common marmoset callithrix jacchus.
16338454 - The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acu...
15038834 - The extracellular matrix, p53 and estrogen compete to regulate cell-surface fas/apo-1 s...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-14
Journal Detail:
Title:  The American journal of pathology     Volume:  174     ISSN:  1525-2191     ISO Abbreviation:  Am. J. Pathol.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-25     Completed Date:  2009-06-23     Revised Date:  2014-03-10    
Medline Journal Info:
Nlm Unique ID:  0370502     Medline TA:  Am J Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2290-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Differentiation / genetics,  immunology*
Central Nervous System / immunology,  pathology
Encephalomyelitis, Autoimmune, Experimental / genetics,  immunology*,  pathology*
Enzyme-Linked Immunosorbent Assay
Mice, Knockout
Mice, Transgenic
Myelin Sheath / immunology*,  pathology*
Oligodendroglia / pathology
T-Lymphocytes / immunology
Reg. No./Substance:
0/Antigens, Differentiation; 0/Pdcd1 protein, mouse
Erratum In:
Am J Pathol. 2009 Sep;175(3):1349

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice.
Next Document:  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.